Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Obesema 0.25 mg Injection is a prescription medication manufactured by Alkem Laboratories containing the active ingredient Semaglutide. It is a GLP-1 receptor agonist primarily used for chronic weight management and type 2 diabetes management. The 0.25 mg dose is typically the initial initiation or titration dose used to help the body adjust to the medication
| Active Ingredient | Semaglutide 1mg/1.5ml (0.68mg/ml) |
| Strength | 0.25 mg |
| Product Type | Pre-filled Pen / Injection Kit |
| Product Type | Pre-filled Pen / Injection Kit |